1-5 of 5
Lena Brandefors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib in Combination with Dexamethasone, Rituximab and Cyclophosphamide (B-DRC) As First - Line Treatment of Waldenstrom's Macroglobulinemia: Results of a Prospectively Randomized Multicenter European Phase II Trial

Christian Buske, MD, Meletios A Dimopoulos, Alexander Grunenberg, MD, Efstathios Kastritis, MD, Cecile Tomowiak, MD, Béatrice Mahé, MD, Xavier Troussard, MD, Roman Hajek, MD PhD, Andreas Viardot, Professor Dr, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, MD, Hacene Zerazhi, MD, Benedicte Hivert, MD, Veronique Leblond, MD PhD, Sophie de Guibert, MD, Lena Brandefors, Ramon Garcia-Sanz, Maria Gomes da Silva, MD, Eva Kimby, MD PhD, Jens Dreyhaupt, Rainer Muche, Pierre Morel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-140933
Published: 2020
Journal Articles

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL C omplete Project

Mats Jerkeman, MD PhD, Thorgerdur Palsdottir, Ingrid Glimelius, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Caroline Weibull, Fredrik Ellin, MD PhD, Kristina Sonnevi, MD PhD, Catharina Lewerin, MD PhD, Lena Brandefors, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-133292
Published: 2020
Journal Articles

Waldenstrom's Macroglobulinemia and Overall Survival in Relation to Prognostic Factors and First Line Treatment: An Observational Study from Swedish Lymphoma Registry

Lena Brandefors, MD, Beatrice Melin, MD PhD Prof, Jack Lindh, Prof Emeritus, Lundqvist Kristina, statistician, Eva Kimby, MD professor
Journal: Blood
Blood (2016) 128 (22): 1805.
https://doi.org/10.1182/blood.V128.22.1805.1805
Published: 2016
Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Francesco d'Amore, Sirpa Leppä, Maria Gomes da Silva, Thomas Relander, Peter De Nully Brown, Eckhart Weidmann, Grete Fossum Lauritzsen, Antonio Pezzutto, Achiel Van Hoof, Michel van Gelder, Jeanette K Doorduijn, Ka Lung Wu, MD, PhD, J.C. Kluin-Nelemans, P.J. Lugtenburg, Milada Jankovska, Mats Merup, Unn-Merete Fagerli, Jan Walewski, Hans Hagberg, Jose Mario Mariz, Per Boye Hansen, Thomas Nösslinger, Ann Janssens, Lena Brandefors, Hilde Demuynck, Martyn Ronald Schaafsma, Ilse Christiansen, David Salek, Sirkku Jyrkkiö, Vit Prochazka, Josee Zijlstra, L. Böhmer, Richard Greil, MD, Wendy Stevens, Rob Fijnheer, Marinus van Marwijk Kooy, Matthias Grube, Georg Hopfinger, MD, Eric Van den Neste, Esa Jantunen, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Helle Toldbod
Journal: Blood
Blood (2012) 120 (21): 57.
https://doi.org/10.1182/blood.V120.21.57.57
Published: 2012
Journal Articles

Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,

Magnus Tobiasson, MD, Lena Brandefors, MD, Ingunn Dybedal, MD, PhD, Hege Garelius, MD, Michael Grövdal, MD, PhD, Inge Hoegh Dufva, MD, PhD, Lars Kjeldsen, MD, PhD, Lars Nilsson, MD, PhD, Astrid Olsnes Kittang, MD, PhD, Anna Porwit, MD, PhD, Leonie Saft, MD, Mette Skov Holm, MD, PhD, Lars Möllgård, MD, Phd, Eva Hellström-Lindberg
Journal: Blood
Blood (2011) 118 (21): 3798.
https://doi.org/10.1182/blood.V118.21.3798.3798
Published: 2011